KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
about
The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testingClinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyondMurine Models of Splenic Marginal Zone Lymphoma: A Role for Cav1?Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencingThe genetics of nodal marginal zone lymphomaDeregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing.The molecular pathogenesis of B-cell non-Hodgkin lymphoma.Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole exome sequencing.Spectrum and immunophenotyping of 653 patients with B-cell chronic lymphoproliferative disorders in China: A single-centre analysis.Genetic landscape and deregulated pathways in B-cell lymphoid malignancies.Chronic lymphocytic leukemia: Time to go past genomics?Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment.Differential gene expression profiling linked to tumor progression of splenic marginal zone lymphoma.Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma.Maintenance of the marginal-zone B cell compartment specifically requires the RNA-binding protein ZFP36L1.A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma.Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.Clinical and diagnostic relevance of NOTCH2-and KLF2-mutations in splenic marginal zone lymphoma.Significant functional difference between TNFAIP3 truncation and missense mutants.New developments in the pathology of malignant lymphoma: a review of the literature published from October 2014-December 2014.Drug-perturbation-based stratification of blood cancer.Role of Bruton's tyrosine kinase in B cells and malignancies.Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma.Genomics of Hairy Cell Leukemia.Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.Recent advances in understanding the biology of marginal zone lymphoma.Recent advances in understanding and managing hairy cell leukemia.New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes.PD1 cells associate with clusters of proliferating B-cells in marginal zone lymphomaGenetic Alterations of TRAF Proteins in Human Cancers
P2860
Q26784600-FB48E0A9-E9F3-4371-9881-BEA927565001Q27027493-DBBB822D-8308-465D-943C-254D1F39F819Q28070123-3CC0307C-C087-468B-92F0-7DF12B6DEC66Q33566663-CC43E48B-BC61-4F13-AA78-9465C02D0DD4Q35812737-5A422E23-4962-466D-9C2F-7F58E20853F7Q36203511-DD4CCB7D-0DFF-407B-9D63-980D04762981Q36849273-07155529-3C79-4B3F-9A2C-A6C01C687E89Q37243257-26BA2FCC-AD8C-4639-AD51-38E774F95B97Q38384041-6D8ABA21-2E6E-42A1-997A-BC5EFFCFCA29Q38385507-95BCFFAE-194A-427A-A4B7-AE3B6E9BC0EBQ38495121-60DAB161-930F-495D-9563-F985F406EF7FQ38616932-50BC1C1D-AB61-4B3C-9123-8F1AC69520B4Q38650484-0C6369FD-92A3-4C62-90A2-DD0C3EB9DAC7Q38669131-5207F6A4-422D-4FD5-AB54-4E9A7009C789Q38708220-2B144785-39AA-4EF8-9720-94EC55E08A3BQ38819164-7B29BFC1-ADDA-4C19-BEF0-DA33A65175DFQ38988815-003E6837-D3D1-4A81-A61F-891B9AF69726Q39230986-CB0E522B-EF46-4E92-B8E4-AFD4973D0CE9Q40059586-27816E9D-97EB-4587-B6E8-CDDF13248289Q40145663-6295BDA7-849F-4DC1-9100-C1968B21CB41Q40258088-E62B87F3-CBAD-44D1-9BCD-F5BAA7049EC5Q41288484-7B38093B-5473-4E2F-A8EF-20A8D3906790Q42122171-9A7D7146-98CE-4922-B723-1DADA6D53496Q42341705-86594270-E0E0-4FDE-B702-8D18B5F952D9Q42384348-A14776C9-AA81-4DC1-8676-CE5F90B2D9E1Q43184380-D12F5150-5546-4C5C-AA4B-27B3EC516466Q47331796-7BD69D64-45E1-47B2-8A03-17EAFFF91C36Q49888075-C8C4B70B-4D75-499A-ABE7-FD4955CF47FDQ52653323-24E8058F-0FBD-486A-B93D-B401D156EF01Q52781884-51ACC6E7-97DD-473B-BE28-6134A835C257Q52863070-D69ED78C-E85D-424E-BC30-FDF017008138Q55106506-B571A70B-7884-4F4C-856F-F7E3D6CC8346Q55396457-48AF6573-D834-43CB-8A13-7292BD3AB93CQ55508866-483EFACE-B92B-44A1-98C1-CD5FB99609AFQ57156812-7F146187-5DCA-4AD0-AD49-452C1CA5C72EQ57191736-3532043C-4CED-4883-B886-B2E22FDC14A9
P2860
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
KLF2 mutation is the most freq ...... subset with distinct genotype.
@en
KLF2 mutation is the most freq ...... subset with distinct genotype.
@nl
type
label
KLF2 mutation is the most freq ...... subset with distinct genotype.
@en
KLF2 mutation is the most freq ...... subset with distinct genotype.
@nl
prefLabel
KLF2 mutation is the most freq ...... subset with distinct genotype.
@en
KLF2 mutation is the most freq ...... subset with distinct genotype.
@nl
P2093
P2860
P50
P356
P1433
P1476
KLF2 mutation is the most freq ...... subset with distinct genotype.
@en
P2093
A J Watkins
A Wotherspoon
E F Robles
P2860
P2888
P304
P356
10.1038/LEU.2014.330
P577
2014-11-27T00:00:00Z